Relay Therapeutics Cash Flow Statement 2019-2024 | RLAY

Fifteen years of historical annual cash flow statements for Relay Therapeutics (RLAY).

Annual Data | Millions of US $ except per share data

Metric Name
Net Income/Loss
Total Depreciation And Amortization - Cash Flow
Other Non-Cash Items
Total Non-Cash Items
Change In Accounts Receivable
Change In Inventories
Change In Accounts Payable
Change In Assets/Liabilities
Total Change In Assets/Liabilities
Cash Flow From Operating Activities
Net Change In Property, Plant, And Equipment
Net Change In Intangible Assets
Net Acquisitions/Divestitures
Net Change In Short-term Investments
Net Change In Long-Term Investments
Net Change In Investments - Total
Investing Activities - Other
Cash Flow From Investing Activities
Net Long-Term Debt
Net Current Debt
Debt Issuance/Retirement Net - Total
Net Common Equity Issued/Repurchased
Net Total Equity Issued/Repurchased
Total Common And Preferred Stock Dividends Paid
Financial Activities - Other
Cash Flow From Financial Activities
Net Cash Flow
Stock-Based Compensation
Common Stock Dividends Paid
20232022202120202019
$-341.97$-290.51$-363.87$-52.41$-75.31
$-5.49$5.31$5.98$3.13$0.35
$79.61$44.46$186$31.96$4.51
$74.12$49.77$192$35.09$4.86
$0.31$0.10$74.68$-75.00$0
$0$0$0$0$0
$-2.39$1.99$0.93$-0.41$3.00
$1.77$-10.90$0.74$-11.77$-0.89
$-32.46$11.25$97.34$-85.17$4.31
$-300.32$-229.49$-74.41$-102.49$-66.13
$-4.13$-9.06$-3.47$-1.93$-7.98
$0$0$0$0$0
$0$0$-25.30$0$0
$647$356$530$350$242
$-385.54$-535.42$-980.67$-266.46$-553.52
$262$-179.68$-450.74$83.60$-311.04
$0$0$0$0$0
$258$-188.75$-479.51$81.67$-319.02
$0$0$0$0$0
$0$0$0$0$0
$0$0$0$0$0
$34.75$290$388$427$0.61
$34.75$290$388$427$5.61
$0$0$0$0$0
$0$0$0$0$0
$34.75$290$388$427$5.61
$-7.93$-128.33$-165.83$406$-379.55
$86.03$56.14$48.45$31.96$4.46
$0$0$0$0$0